Management Team   BOD   SAB   CAB   About Metabolic Diseases
  Home > About > Board of Directors > Investors  
Metabolex is privately held. We are supported by investors who have invested an aggregate of $117 million since August 2003. Our major investors include:
Alta Partners KBC Funds
Alliance Bernstein Merlin Biomed Group
Bay City Capital Novo Ventures
Birchmere Ventures Pictet Funds (LUX)
Biotech Turnaround Fund BV T. Rowe Price
Charter Life Sciences VantagePoint Ventures
Deerfield Management Venrock Partners
Johnson & Johnson Development Corporation Versant Ventures